168 related articles for article (PubMed ID: 8228934)
21. Immunogenicity of a recombinant DNA hepatitis B vaccine in neonates.
Meheus A; Alisjahbana A; Vranckx R; Sukadi A; Usman A; Ngantung W; Sugita E; Safary A; André F; Reniers J
Postgrad Med J; 1987; 63 Suppl 2():139-41. PubMed ID: 3317350
[TBL] [Abstract][Full Text] [Related]
22. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
23. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
Keating GM; Noble S
Drugs; 2003; 63(10):1021-51. PubMed ID: 12699402
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and efficacy of a recombinant DNA hepatitis B vaccine, GenHevac B Pasteur in high risk neonates, school children and healthy adults.
Assateerawatt A; Tanphaichitr VS; Suvatte V; Yodthong S
Asian Pac J Allergy Immunol; 1993 Jun; 11(1):85-91. PubMed ID: 8216564
[TBL] [Abstract][Full Text] [Related]
25. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose.
Wiström J; Ahlm C; Lundberg S; Settergren B; Tärnvik A
Vaccine; 1999 Apr; 17(17):2162-5. PubMed ID: 10367949
[TBL] [Abstract][Full Text] [Related]
26. Combined intramuscular-intradermal protocol of universal neonate HB vaccination irrespective of mother's status of HBsAg.
Yao FB; Li XX; Du YX; Ye SL
Vaccine; 1998 Apr; 16(6):586-9. PubMed ID: 9569469
[TBL] [Abstract][Full Text] [Related]
27. Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adults.
Aguilar-Betancourt A; González-Delgado CA; Cinza-Estévez Z; Martínez-Cabrera J; Véliz-Ríos G; Alemán-Zaldívar R; Alonso-Martínez MI; Lago-Baños M; Puble-Alvarez N; Delahanty-Fernandez A; Juvier-Madrazo AI; Ortega-León D; Olivera-Ruano L; Correa-Fernández A; Abreu-Reyes D; Soto-Mestre E; Pérez-Pérez MV; Figueroa-Baile N; Pérez LH; Rodríguez-Silva A; Martínez-Díaz E; Guillén-Nieto GE; Muzio-González VL
Hum Vaccin; 2008; 4(1):54-9. PubMed ID: 18441530
[TBL] [Abstract][Full Text] [Related]
28. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
[TBL] [Abstract][Full Text] [Related]
30. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
[TBL] [Abstract][Full Text] [Related]
31. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients.
Lefebure AF; Verpooten GA; Couttenye MM; De Broe ME
Vaccine; 1993; 11(4):397-9. PubMed ID: 8470423
[TBL] [Abstract][Full Text] [Related]
33. Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene TF and Engerix-B Recombinant Hepatitis B Vaccines in Neonates in China.
Zhu F; Deckx H; Roten R; Michiels B; Sarnecki M
Pediatr Infect Dis J; 2017 Jan; 36(1):94-101. PubMed ID: 27753794
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus vaccination for older adults.
Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
[TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates.
Minervini G; McCarson BJ; Reisinger KS; Martin JC; Stek JE; Atkins BM; Nadig KB; Liska V; Schödel FP; Bhuyan PK
Vaccine; 2012 Feb; 30(8):1476-80. PubMed ID: 22227229
[TBL] [Abstract][Full Text] [Related]
38. A multi-center controlled study of rapid hepatitis B vaccination using a novel triple antigen recombinant vaccine.
Young MD; Rosenthal MH; Dickson B; Du W; Maddrey WC
Vaccine; 2001 May; 19(25-26):3437-43. PubMed ID: 11348708
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life.
Freitas da Motta MS; Mussi-Pinhata MM; Jorge SM; Tachibana Yoshida CF; Sandoval de Souza CB
Vaccine; 2002 Feb; 20(11-12):1557-62. PubMed ID: 11858862
[TBL] [Abstract][Full Text] [Related]
40. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
